Laura Rodríguez-Pascau

6PUBLICATIONS
29CO-AUTHORS
Biomolecular modelling and designCancer diagnosisPharmacogenomicsCellular nervous systemMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Development of Small-Molecule Allosteric Modulators of Beta-Galactosidase (β-Gal) for the Treatment of GM1 Gangliosidosis and Morquio B.

|Sep 04, 2024
Cannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models.

Emma Puighermanal, Marta Luna-Sánchez, Alejandro Gella

|Mar 29, 2024
Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children.

Estefania Traver, Laura Rodríguez-Pascau, Uwe Meya

|Feb 25, 2023
Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate.

Pilar Pizcueta, Cristina Vergara, Marco Emanuele

|Jan 21, 2023
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes.

Paolo Santambrogio, Anna Cozzi, Ivano Di Meo

|Jun 03, 2021
The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy.

Laura Rodríguez-Pascau, Anna Vilalta, Marc Cerrada

Pageof 1

Frequent Collaborators

3 joint publications

Pilar Pizcueta

2 joint publications

Anna Vilalta

1 joint publications

Jan Bauer

1 joint publications

Stephan Kemp